clinical trial · NCT04278404
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Coronavirus Infection (COVID-19)Pulmonary Arterial HypertensionUrinary Tract Infections in ChildrenHypertensionPainHyperphosphatemiaPrimary HyperaldosteronismEdemaThe POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:
brief summary
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.
started
Mar 5, 2020
primary completion
Nov 1, 2026
completion
Dec 1, 2026
last updated
Aug 21, 2026
official title
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol